HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation.

Abstract
The A to G mitochondrial DNA point mutation at position 3243 (A3243G) is the most common cause of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS), a systemic multiorgan disease. Epilepsy is a common finding but there is wide phenotypic variation that has not been thoroughly explored. We report the epilepsy phenotypes of 7 patients with the A3243G mutation. Most presented with typical MELAS and epilepsy characterized by infrequent prolonged focal seizures, including epilepsia partialis continua, hemiclonic status epilepticus, nonconvulsive status, and occipital status epilepticus. Seizures usually occurred during the acute phase of a strokelike episode. Periodic lateralized epileptiform discharges may be seen electrographically. Some patients with this mutation are completely asymptomatic or have mild symptoms typical for mitochondrial diseases. Slow spike-wave activity consistent with Lennox-Gastaut syndrome and electrographic status epilepticus was seen in 1 patient who responded to ethosuximide.
AuthorsScott T Demarest, Matthew T Whitehead, Sinan Turnacioglu, Phillip L Pearl, Andrea L Gropman
JournalJournal of child neurology (J Child Neurol) Vol. 29 Issue 9 Pg. 1249-56 (Sep 2014) ISSN: 1708-8283 [Electronic] United States
PMID25038129 (Publication Type: Case Reports, Journal Article)
Copyright© The Author(s) 2014.
Chemical References
  • DNA, Mitochondrial
Topics
  • Adolescent
  • Adult
  • Brain (physiopathology)
  • Child
  • DNA, Mitochondrial
  • Electroencephalography
  • Epilepsy (genetics, physiopathology)
  • Female
  • Humans
  • MELAS Syndrome (genetics, physiopathology)
  • Male
  • Phenotype
  • Point Mutation
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: